Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 232 Results Clear All
Gladstone's Magnus Hoffmann seeks to advance a new generation of more effective vaccines, improved drug delivery methods, and a greater overall understanding of vaccine-induced immune responses.
COVID-19 Data Science and Biotechnology Infectious Disease
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Infectious Disease Ott Lab
Virologist Sukrit Silas hopes to turn bacteria-killing viruses into new therapies that hold promise against even the most persistent superbugs.
News Release Profile Infectious Disease
Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.
Gladstone Experts Infectious Disease Doudna Lab
A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.
News Release Research (Publication) COVID-19 Neurological Disease Infectious Disease Akassoglou Lab
The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.
Gladstone Experts Infectious Disease Ott Lab
Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies
News Release Research (Publication) Data Science and Biotechnology Infectious Disease Doudna Lab CRISPR/Gene Editing
San Francisco Chronicle—With the United States now experiencing a typical summer COVID surge, Gladstone Senior Investigator Nadia Roan helps break down how to make a personal decision about when to get your next vaccine.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
Science News—In some people with long COVID, powerful immune players called T cells seem to go out of whack. In some long COVID patients, T cells that recognize SARS-CoV-2 can become exhausted, Nadia Roan's team reported in Nature Immunology in January. And scientists know that tired-out T cells can have trouble wiping out infection.
Research (Publication) COVID-19 Infectious Disease Roan Lab
San Francisco Chronicle—At least 10 percent of those who survive COVID continue to face debilitating symptoms months after the acute infection resolves. New research from the laboratory of Gladstone Senior Investigator Nadia Roan shows that individuals suffering Long Covid have a dysregulated immune response to the virus and evidence of T cell exhaustion, which may be due to the virus persisting within their bodies.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
Scientists at Gladstone Institutes and UC San Francisco analyzed immune cells in people with and without long COVID, making significant discoveries that will help answer questions about what causes the condition and how to treat it
News Release Research (Publication) COVID-19 Infectious Disease Roan Lab
Melanie Ott, director of the Gladstone Institute of Virology, reflects on the breakthroughs driven by the COVID-19 pandemic and explains why virologists’ work is never done
Gladstone Experts COVID-19 Infectious Disease Ott Lab
Fortune—Researchers are investigating the possibility that people who suffer from Long COVID might be at elevated risk of developing cancer. Melanie Ott, director of the Gladstone Institute of Virology, explains that viruses related to SARS-CoV-2 have been shown to inactivate oncosuppressor proteins, which may predispose patients to cancer.
Gladstone Experts Cancer COVID-19 Infectious Disease Ott Lab
New research sheds light on the biological effect of the many possible three-dimensional structures of a critical loop of RNA in HIV
Research (Publication) HIV/AIDS Infectious Disease Ott Lab
The Atlantic—The next generation of COVID vaccines may be directed against just one lineage of the Omicron strain. Melanie Ott, director of the Gladstone Institute of Virology, explains why that could be a smart strategy to elicit a strong immune response.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
